CORONARY ATHEROSCLEROSIS MANAGEMENT

Clinical trials for CORONARY ATHEROSCLEROSIS MANAGEMENT explained in plain language.

Never miss a new study

Get alerted when new CORONARY ATHEROSCLEROSIS MANAGEMENT trials appear

Sign up with your email to follow new studies for CORONARY ATHEROSCLEROSIS MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Genetic clue could guide heart drug use in Post-Heart attack patients

Disease control Not yet recruiting

This study is testing if a low-dose anti-inflammatory drug (colchicine) can slow the progression of coronary artery plaque in people who have recently had a heart attack. It specifically aims to see if the drug works better for patients who have a certain genetic marker called TE…

Matched conditions: CORONARY ATHEROSCLEROSIS MANAGEMENT

Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

CORONARY ATHEROSCLEROSIS MANAGEMENT

Get alerted when new CORONARY ATHEROSCLEROSIS MANAGEMENT trials appear

Genetic clue could guide heart drug use in Post-Heart attack patients